Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Investing Activities (2016 - 2025)

Biomerica's Cash from Investing Activities history spans 16 years, with the latest figure at -$4000.0 for Q1 2025.

  • For Q1 2025, Cash from Investing Activities rose 75.0% year-over-year to -$4000.0; the TTM value through May 2025 reached -$44000.0, up 61.74%, while the annual FY2025 figure was -$37000.0, 67.83% up from the prior year.
  • Cash from Investing Activities for Q1 2025 was -$4000.0 at Biomerica, up from -$24000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$4000.0 in Q1 2025 and bottomed at -$100539.0 in Q1 2021.
  • The 5-year median for Cash from Investing Activities is -$24000.0 (2022), against an average of -$35965.4.
  • The largest annual shift saw Cash from Investing Activities tumbled 231.53% in 2021 before it surged 81.25% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$49613.0 in 2021, then soared by 51.63% to -$24000.0 in 2022, then soared by 50.0% to -$12000.0 in 2023, then plummeted by 100.0% to -$24000.0 in 2024, then skyrocketed by 83.33% to -$4000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Cash from Investing Activities are -$4000.0 (Q1 2025), -$24000.0 (Q2 2024), and -$16000.0 (Q1 2024).